Emilio Amilibia

ORCID: 0000-0003-0587-7891
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Neurofibromatosis and Schwannoma Cases
  • Meningioma and schwannoma management
  • Ear Surgery and Otitis Media
  • Salivary Gland Tumors Diagnosis and Treatment
  • Vestibular and auditory disorders
  • Facial Nerve Paralysis Treatment and Research
  • Hearing, Cochlea, Tinnitus, Genetics
  • Sarcoma Diagnosis and Treatment
  • Bone Tumor Diagnosis and Treatments
  • Ear and Head Tumors
  • Soft tissue tumors and treatment
  • Trigeminal Neuralgia and Treatments
  • Chromatin Remodeling and Cancer
  • Infectious Diseases and Tuberculosis
  • Head and Neck Cancer Studies
  • Head and Neck Surgical Oncology
  • Neuroscience of respiration and sleep
  • Reconstructive Facial Surgery Techniques
  • Cancer Diagnosis and Treatment
  • Soft tissue tumor case studies
  • Neuroblastoma Research and Treatments
  • Ocular Oncology and Treatments
  • Oral and Maxillofacial Pathology
  • Full-Duplex Wireless Communications
  • Leprosy Research and Treatment

Hospital Universitari Germans Trias i Pujol
2020-2023

Universitat Autònoma de Barcelona
2021-2022

Institut Cartogràfic i Geològic de Catalunya
2022

Montavid Thermodynamic Research Group
2020

Hospital Municipal de Badalona
2015

USP Institut Universitari Dexeus
2011

Bellvitge University Hospital
1998-2001

Ajuntament de L’Hospitalet
2000

Cochlear implants (CIs) are a well-known hearing restoration option for patients with vestibular schwannoma (VS) in cases of neurofibromatosis type-2 and, more recently, sporadic VS. One the main limitations when performing CI during VS surgery is capability to preserve acoustic nerve (AN) anatomically and functionally. Significant efforts have been directed toward developing an intraoperative testing method monitoring AN function determine if, after tumor removal, it suitable conducting...

10.1097/aud.0000000000000883 article EN Ear and Hearing 2020-08-04

A clinical overlap exists between mosaic Neurofibromatosis Type 2 and sporadic Schwannomatosis conditions. In these cases a molecular analysis of tumors is recommended for proper genetic diagnostics. This challenged by the fact that schwannomas in both conditions bear somatic double inactivation NF2 gene. However, SMARCB1-associated follow four-hit, three-step model, which alleles SMARCB1 genes are inactivated tumor, with one steps being always loss big part chromosome 22 involving loci.Here...

10.1186/s12920-015-0076-2 article EN cc-by BMC Medical Genomics 2015-01-23

Abstract Purpose The study assesses whether pre- and intraoperative factors linked to electromyography direct electrical stimulation (DES) of facial nerve can predict function in the short- (12 days) long-term (1 year) after cerebellopontine angle (CPA) tumor resection. Methods 157 patients who underwent surgical resection CPA tumors with monitoring. Pre-operative (age, size, pure tone average), time intra-operative parameters regarding function, minimum threshold (MST), compound muscle...

10.1007/s00405-022-07556-8 article EN cc-by European Archives of Oto-Rhino-Laryngology 2022-07-30

Neurofibromatosis type 2 (NF2) is a devastating genetic condition characterized by the development of multiple tumors nervous system. An early diagnosis individuals with NF2 would facilitate treatment and reduction disease impact because most severe effects do not usually develop before adolescence. Little attention has traditionally been paid to dermatological signs in NF2. However, skin plaques are commonly seen patients NF2, normally appearing either at birth or childhood, providing an...

10.1001/jamadermatol.2017.5464 article EN JAMA Dermatology 2018-01-10

Hair cell (HC) loss by epithelial extrusion has been described to occur in the rodent vestibular system during chronic 3,3'-iminodipropionitrile (IDPN) ototoxicity. This is preceded dismantlement of calyceal junction contact between type I HC (HCI) and calyx afferent terminals. Here, we evaluated whether these phenomena have wider significance. First, studied rats receiving seven different doses streptomycin, ranging from 100 800 mg/kg/day, for 3-8 weeks. Streptomycin caused function...

10.1007/s00204-023-03518-z article EN cc-by Archives of Toxicology 2023-05-17

Neurofibromatosis type 2 (NF2) is an autosomal dominant disorder characterised by the development of multiple schwannomas, especially on vestibular nerves, and meningiomas. The UK NF2 Genetic Severity Score (GSS) useful to predict progression disease from germline pathogenic variants, which allows clinical follow-up genetic counselling offered affected families be optimised.52 Spanish patients were classified using GSS, patients' severity was measured compared between GSS groups. reviewed...

10.1136/jmedgenet-2020-107548 article EN Journal of Medical Genetics 2021-08-04

Bilateral facial nerve palsy is relatively uncommon and may occur in association with a variety of neurological, infectious, neoplastic or degenerative disorders. Presentation made 4 cases bilateral diplegia due to refractory anemia excess blasts, Lyme disease tuberculoid leprosy. In one these patients the cause seventh-nerve was unknown (Bell’s palsy). Facial returned normal after treatment steroids 3 patients. The patient myelodysplastic syndrome did not show any improvement died 6 months...

10.1159/000027599 article EN ORL 1998-01-01

Cruz Toro, Paula; Domenech, Ivan; Clemente, Ignacio; Farré, Anna; Amilibia, Emili Author Information

10.1097/mao.0b013e31821a498d article EN Otology & Neurotology 2011-04-28

ABSTRACT Hair cell (HC) loss by epithelial extrusion has been described to occur in the rodent vestibular system during chronic 3,3’-iminodipropionitrile (IDPN) ototoxicity. This is preceded dismantlement of calyceal junction contact between type I HC (HCI) and calyx afferent terminals. Here, we evaluated whether these phenomena have wider significance. First, studied rats receiving streptomycin for 3 8 weeks. Streptomycin caused function associated with partial HCI decreased expression...

10.1101/2022.05.17.492294 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-05-18

Objectives: To study computed tomography findings in Paget's disease of temporal bone (PDTB) and analyze the relations between otic capsule mineral density values measured Hounsfield Units (HU) hearing loss (HL). Study Design: Observational case-control study. Setting: Tertiary referral center. Patients: Radiographically confirmed PDTB cases control group. Intervention: Diagnostic. Main Outcome Measures: Hearing thresholds values. Results: Twenty-three ears case group 27 were included. In...

10.1097/mao.0000000000003077 article EN Otology & Neurotology 2021-03-11

Abstract Background Neurofibromatosis Type 2 (NF2) is an autosomal dominant disorder characterized by the development of multiple schwannomas, particularly at vestibular nerves, and meningiomas. The UK NF2 Genetic Severity Score (GSS) helps predicting disease course from germline pathogenic variants, optimizing clinical follow-up genetic counselling offered to affected families. Methods Spanish Reference Center patients were classified following GSS patients’ severity was measured compared...

10.1101/2020.10.22.20216614 preprint EN medRxiv (Cold Spring Harbor Laboratory) 2020-10-26

ABSTRACT NF2-related schwannomatosis is an autosomal dominant syndrome that predisposes to the development of benign tumors nervous system. Schwannomas, particularly bilateral vestibular schwannomas (VS), are most characteristic features disease. These caused by bi-allelic inactivation NF2 gene in a cell Schwann lineage. Our current understanding molecular pathogenesis gene, as well new effective therapies hampered absence human non-perishable cell-based bearing distinct pathogenic variants....

10.1101/2022.12.14.520389 preprint EN cc-by-nc-nd bioRxiv (Cold Spring Harbor Laboratory) 2022-12-14
Coming Soon ...